COVID-19
laboratory diagnosis for clinicians. An updating article
Palavras-chave:
Coronavirus, Clinical laboratory techniques, Pandemics, Molecular biologyResumo
COVID-19 (coronavirus disease 2019) is an infectious disease caused by the new coronavirus associated with severe acute respiratory syndrome 2 (SARS-CoV-2). Coronaviridae comprises a large family, of which at least seven members are known to cause respiratory diseases in humans. Coronaviruses have the ability to infect virtually all major groups of animals and, eventually, can infect humans. SARS-CoV-2 is the third coronavirus to cross the species barrier and infect humans. This virus was identified in an outbreak of pneumonia cases in Wuhan city, Hubei province, China, in December 2019. Its entire genome is inscribed on a single strand of ribonucleic acid. Some proteins present on the surface of the virus act as facilitators for its entry into host cells, while others, apparently, are related to its pathogenesis. Coronaviruses are responsible for respiratory infections in humans and some animals. The infection is often mild to moderate in intensity, but some coronaviruses may cause serious illnesses, such as severe acute respiratory syndrome (SARS), which occurred in 2002, and the Middle East respiratory syndrome (MERS). Coronaviruses can activate an excessive and unregulated immune response, which may promote SARS development. Although the lungs are one of the target organs, the hypoxia mechanism is systemic and other organs begin to suffer both through lack of oxygen and through deregulation of inflammation control mechanisms.
Downloads
Referências
Knipe DM, Roizman B, Straus SE et al. Fields Virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. ISBN-13: 978-0-7817-1832-5.
Centers for Disease Control and Prevention (CDC). Coronavirus Disease 2019 (COVID-19). Symptoms of Coronavirus. Available from: Available from: https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms.html Accessed in 2020 (29 Apr).
Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS. Association of chemosensory dysfunction and Covid-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. 2020. PMID: 32279441; doi: 10.1002/alr.22579. Online ahead of print.
Britt RR. From Infection to Recovery: How Long It Lasts. [publication on the web]; 2020. Available from: Available from: https://elemental.medium.com/from-infection-to-recovery-how-long-it-lasts-199e266fd018 Accessed in 2020 (29 Apr).
Ferguson NM, Laydon D, Nedjati-Gilani G, et al. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Imperial College COVID-19 Response Team. 2020. doi: 10.25561/77482.
Gorbalenya AE. Severe acute respiratory syndrome-related coronavirus: The species and its viruses - a statement of the Coronavirus Study Group. bioRxiv preprint; 2020 doi: 10.1101/2020.02.07.937862.
Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020. PMID: 32091533; doi: 10.1001/jama.2020.2648. Online ahead of print.
Ministério da Saúde. Boletim COE COVID-19. Centro de Operações de Emergência em Saúde Pública/Doença pelo coronavírus 2019. Boletim Epidemiológico 12 - COE COVID-19. 2020. Available from: Available from: https://portalarquivos.saude.gov.br/images/pdf/2020/April/19/BE12-Boletim-do-COE.pdf Accessed in 2020 (Apr 29).
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. PMID: 32007143; doi: 10.1016/S0140-6736(20)30211-7.
Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. JAMA. 2020;323(20):2085-6. PMID: 32293646; doi: 10.1001/jama.2020.6266.
Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Guia para a Rede Laboratorial de Vigilância de Influenza no Brasil [recurso eletrônico]/Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância das Doenças Transmissíveis. Brasília: Ministério da Saúde; 2016. Available from: Available from: https://bvsms.saude.gov.br/bvs/publicacoes/guia_laboratorial_influenza_vigilancia_influenza_brasil.pdf Accessed in 2020 (May 7).
The Royal College of Pathologists Australasia (RCPA). RCPA advises against COVID-19 IgG/IgM rapid tests for the detection of early COVID disease. Media Release, April 1, 2020. Available from: Available from: https://www.rcpa.edu.au/getattachment/6a74686a-e558-4efa-bc6c-a9921b7837df/RCPA-advises-against-COVID-19-IgGIgM-rapid-tests-f.aspx Accessed in 2020 (Apr 29).
Wang Q, Fang P, He R, et al. O-GlcNAc transferase promotes influenza A virus-induced cytokine storm by targeting interferon regulatory factor-5. Science Advances. 2020;6(16):eaaz7086. Available from: Available from: https://advances.sciencemag.org/content/6/16/eaaz7086.full Accessed in 2020 (May 7).
Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846-8. PMID: 32125452; doi: 10.1007/s00134-020-06028-z.
Carter J, Saunders V. Virology: Principles and Applications. Chichester: Wiley; 2007. ISBN: 978-0-470-02386-0.
Ramos-Casals M, Brito-Zerón P, López-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014;383(9927):1503-16. PMID: 24290661; doi: 10.1016/S0140-6736(13)61048-X.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. PMID: 31986264; doi: 10.1016/S0140-6736(20)30183-5.
Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020. PMID: 32282949; doi: 10.1002/ajh.25829. Online ahead of print.
Seguin A, Galicier L, Boutboul D, Lemiale V, Azoulay E. Pulmonary involvement in patients with hemophagocytic lymphohistiocytosis. Chest. 2016;149(5):1294-301. PMID: 26836913; doi: 10.1016/j.chest.2015.11.004.
Downloads
Publicado
Como Citar
Edição
Seção
Licença

Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.